EMBL Ventures is a private equity general partner firm headquartered in Heidelberg, Germany.
EMBL Venture Capital Partners and Life Sciences Partners have sold medical microscope and bio-imaging firm Luxendo to trade buyer Bruker.
Arsanis, a MA-based clinical-stage biopharmal company, closed a $45.5m Series D round from Bill & Melinda Gates Foundation and others.
Developer of single-plane illumination microscopes firm Luxendo has raised €8m in Series A from Life Science Partners and others.
Read more news concerning EMBL Ventures
A sampling of EMBL Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?